GlassScriptPhysician profile
Jacquelyn A Spencer
NPI 1164614962
$1,686.75
in general payments reported to CMS, 2019-2025
9 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $129 · 2023: $656 · 2024: $570 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,053.65 | 2021-2024 | Parsabiv, Aranesp, Tavneos |
| Novo Nordisk INC | $209.63 | 2023-2025 | Wegovy, Ozempic |
| Ardelyx, INC. | $123.48 | 2024 | Xphozah 30 Mg |
| Astrazeneca Pharmaceuticals LP | $111.97 | 2021-2023 | Lokelma |
| Vifor Pharma, INC. | $87.00 | 2021 | |
| Fresenius USA Marketing, INC. | $35.83 | 2022-2025 | Velphoro |
| Ani Pharmaceuticals, INC. | $23.56 | 2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $22.46 | 2025 | |
| Nxstage Medical, INC. | $19.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.